16 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
capital to business development and share repurchases, all of which is expected to better position the Company to deliver sustainable growth and long
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
diseases Foster a culture of integrity and excellence Build sustainable communities Product quality and safety Diverse, healthy and engaged workforce
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
4 May 22
Regeneron Reports First Quarter 2022 Financial and Operating Results
7:08am
results and provide sustainable value to patients and shareholders."
Business Highlights
Key Pipeline Progress
Regeneron has approximately 35 product
8-K
EX-99.1
6wsq pe6io03o
4 Feb 22
Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
7:29am
8-K
EX-99.1
f9gql1cp19vh
5 Aug 21
Regeneron Reports Second Quarter 2021 Financial and Operating Results
6:59am
8-K
EX-99.1
fakgb6ahxouiw2yro4k
6 May 21
Regeneron Reports First Quarter 2021 Financial and Operating Results
7:12am
DEFA14A
uug4zeq
23 Apr 21
Additional proxy soliciting materials
4:21pm
DEFA14A
q43ybpm
24 Apr 20
Additional proxy soliciting materials
4:14pm
DEFA14A
b9zskai
26 Apr 19
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
gofzmb1g nk78h0
13 Jan 15
JP Morgan Healthcare Conference
12:00am
- Prev
- 1
- Next